<That 1 in a million chance that you mentioned is off. I think there were 7 or 8 zeros in the p value, so it should be more like a 1 in 100 million or 1 in a billion that those Avastin Phase 3 results were due to chance. Amazing, isn't it...>
i try to follow biotechs (obviously nowhere near the extent & depth some of you guys do), but when i read stuff like this it boggles my mind as to how this type of apparently transparent impropriety can be allowed to go on.
i no longer hold any financial interest in DNDN and don't actively follow its MB at ivillage only Ihub's DNDN message board with any regularity, but was wondering wall, if you have any thoughts about the lawsuit being brought against the FDA by some DNDN shareholders/prostate cancer patients & advocates (i think it is caretolive.org), specifically its chances of exposing dirt on Scher, the Cancer Letter and who at the FDA was responsible for leaking the letters to TCL and if successful in uncovering any dirt, whether you think there would be enough newsworthiness and/or egregiousness that it might make a difference in a) causing anyone at the FDA involved to be removed from their position and/or b) having the FDA have a new look at the Provenge decision?
fwiw, i hope for the sake of the advancement of science and a healthy biotech sector, this lawsuit succeeds in its goals.
thanks in advance for any thoughts you might have.
